Evolent Health, Inc Class A Common Stock (EVH)
4.2700
+0.4400 (11.49%)
NYSE · Last Trade: May 7th, 8:28 PM EDT
What Happened? Shares of healthcare solutions company Evolent Health (NYSE:EVH) jumped 15.8% in the afternoon session after the company reported decent first...
Via StockStory · May 7, 2026
Evolent Health Inc - A (NYSE:EVH) Q1 Revenue Miss Overshadowed by EPS Beatchartmill.com
Via Chartmill · May 7, 2026
Healthcare solutions company Evolent Health (NYSE:EVH) missed Wall Street’s revenue expectations in Q1 CY2026 as sales rose 2.6% year on year to $496.2 milli...
Via StockStory · May 7, 2026
Healthcare solutions company Evolent Health (NYSE:EVH) will be reporting results this Thursday before the bell. Here’s what investors should know. Evolent He...
Via StockStory · May 5, 2026
What Happened? Shares of healthcare solutions company Evolent Health (NYSE:EVH) jumped 4.1% in the afternoon session after the company reported fourth-quarte...
Via StockStory · April 24, 2026
Evolent Health Inc - A (NYSE:EVH) Reports Q4 Earnings Beat Amid Revenue Decline, Issues Bullish 2026 Guidancechartmill.com
Via Chartmill · February 24, 2026
Looking back on healthcare technology for providers stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Evolent Health (NYSE:...
Via StockStory · April 23, 2026
Health insurance provider Elevance Health (NYSE:EVH) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 2.9% year on year to...
Via StockStory · April 23, 2026
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in...
Via StockStory · April 22, 2026
Health insurance provider Elevance Health (NYSE:EVH) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 2.9% year on year to $50.18 billion....
Via StockStory · April 22, 2026
Health insurance provider Elevance Health (NYSE:EVH) will be reporting results this Wednesday morning. Here’s what to look for. Elevance Health missed analys...
Via StockStory · April 20, 2026
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...
Via StockStory · April 9, 2026
What Happened? A number of stocks jumped in the afternoon session after the government announced a surprise increase in payment rates for Medicare Advantage ...
Via StockStory · April 7, 2026
Evolent Health has gotten torched over the last six months - since October 2025, its stock price has dropped 69.7% to $2.46 per share. This might have invest...
Via StockStory · April 7, 2026
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...
Via StockStory · March 27, 2026
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Via StockStory · March 19, 2026
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...
Via StockStory · March 13, 2026
A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.
Via StockStory · March 6, 2026
A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures.
Via StockStory · February 27, 2026

Privia Health (PRVA) Q4 2025 Earnings Transcript
Via The Motley Fool · February 26, 2026
Shares of healthcare solutions company Evolent Health (NYSE:EVH)
jumped 20.7% in the afternoon session after the company reported fourth-quarter earnings that beat expectations and provided an optimistic revenue forecast for the upcoming year.
Via StockStory · February 25, 2026
KeyBanc downgraded Evolent Health to ‘Sector Weight’ from ‘Overweight’, citing a lack of visibility in near-term EBITDA recovery.
Via Stocktwits · February 25, 2026
Healthcare solutions company Evolent Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 27.5% year on year to $468.7 million. The company’s full-year revenue guidance of $2.5 billion at the midpoint came in 4.9% above analysts’ estimates. Its non-GAAP profit of $0.08 per share was 62.7% above analysts’ consensus estimates.
Via StockStory · February 24, 2026
Healthcare solutions company Evolent Health (NYSE:EVH)
will be announcing earnings results this Tuesday after market close. Here’s what to expect.
Via StockStory · February 22, 2026
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names.
But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
Via StockStory · February 17, 2026